Search results
Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market? | The Motley Fool
The Motley Fool· 5 days agoEli Lilly (LLY -0.03%) sells a broad portfolio of products, but two in particular have helped...
3 Blue Chip Stocks That You Can Buy and Hold for Years | The Motley Fool
The Motley Fool· 12 hours agoThree of the best blue chip stocks to buy, whether you're a seasoned investor or new to Wall Street,...
Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety...
Benzinga· 1 day agoAustralia announced on Wednesday that it would ban compounded versions of weight-loss drugs like...
If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 2 days agoEli Lilly's (NYSE: LLY) broad portfolio of drugs has helped the company's earnings climb over the...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 9 hours agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...
If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today | The...
The Motley Fool· 2 days agoEli Lilly's (NYSE: LLY) broad portfolio of drugs has helped the company's earnings climb over the...
Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise, Tuesday, 5/21/2024
Seattle Times· 2 days agoStocks that are trading heavily or have substantial price changes on Tuesday: Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise.
Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?
Insider Monkey via Yahoo Finance· 1 day agoIn this article, we will be taking a look at is Eli Lilly and Company the largest publicly traded...
Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety...
Benzinga via Yahoo Finance· 1 day agoRecently, the Chinese regulatory authority approved Eli Lilly’s diabetes drug, tirzepatide. Health...
Eli Lilly’s stock on pace for record close as Crohn’s disease trial hits the mark
Market Watch· 2 days agoEli Lilly & Co. LLY shares were on pace for a record closing high Tuesday after the drugmaker...